RSC Stock Hits New 52-Week High (RRR)

NEW YORK ( TheStreet) -- RSC Holdings (NYSE: RRR) hit a new 52-week high Friday as it is currently trading at $23.80, above its previous 52-week high of $23.72 with 339,372 shares traded as of 11:40 a.m. ET. Average volume has been 1.1 million shares over the past 30 days.

RSC has a market cap of $2.53 billion and is part of the services sector and diversified services industry. Shares are up 25.9% year to date as of the close of trading on Thursday.

RSC Holdings Inc., together with its subsidiaries, engages in the rental of construction and industrial equipment primarily in the United States and Canada. The company has a P/E ratio of 78.7, below the average diversified services industry P/E ratio of 81.4 and above the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates RSC as a hold. The company's strengths can be seen in multiple areas, such as its notable return on equity, robust revenue growth and impressive record of earnings per share growth. However, as a counter to these strengths, we also find weaknesses including generally poor debt management and weak operating cash flow. You can view the full RSC Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.

null

More from Markets

Apple Gains as U.S. China Trade Tensions Ease After Weekend Summit

Apple Gains as U.S. China Trade Tensions Ease After Weekend Summit

Global Stocks Rally as US-China Trade War Thaws; Dow Could Test 25,000

Global Stocks Rally as US-China Trade War Thaws; Dow Could Test 25,000

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI